Absent T Lymphocytes

Search Trials
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Status:
Unknown status
Last Changed:
Oct 20, 2015
First Changed:
Oct 20, 2015
Disease(s):
Malignant Mesothelioma
Intervention(s):
anti-meso-CAR vector transduced T cells
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK- Neoplasms
Status:
Completed
Last Changed:
Jul 8, 2021
First Changed:
Apr 10, 2018
Disease(s):
Peripheral T Cell Lymphoma
Intervention(s):
Tislelizumab
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Status:
Completed
Last Changed:
Apr 17, 2014
First Changed:
Dec 15, 2005
Disease(s):
Graft Versus Host Disease
Intervention(s):
graft versus host disease prophylaxis/therapyallogeneic bone marrow transplantationin vitro-treated bone marrow transplantation
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia
Status:
Completed
Last Changed:
Dec 23, 2015
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
anti-thymocyte globulinfilgrastimcyclophosphamidecytarabinemethylprednisolonethiotepain vitro-treated bone marrow transplantationin vitro-treated peripheral blood stem cell transplantationradiation therapy
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Status:
Unknown status
Last Changed:
Dec 6, 2012
First Changed:
May 12, 2009
Disease(s):
Leukemia
Intervention(s):
biologic sample preservation procedure

Connect. Empower. Inspire.